Xingwen Fan

Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study

Francis J. Giles, Philipp D. le Coutre, Javier Pinilla‐Ibarz et al. · Leukemia · 2012 · 246 citations

Chronic Phase, Hematological Malignancy, Chronic Myeloid Leukemia +6

Safety and efficacy of switching to nilotinib 400 mg twice daily for patients with chronic myeloid leukemia in chronic phase with suboptimal response or failure on front-line imatinib or nilotinib 300 mg twice daily

Timothy P. Hughes, Andreas Hochhaus, Hagop M. Kantarjian et al. · Haematologica · 2014 · 48 citations · Full text

[Experts consensus on the management of delirium in critically ill patients].

Bo Tang, X T Wang, Wanying Chen et al. · PubMed · 2019 · 26 citations

Proton and Carbon Ion Radiation Therapy Decreased Severe Lymphopenia by Reducing Thoracic Vertebra and Aortic Doses in Non-Small Cell Lung Cancer Versus Intensity Modulated Radiation Therapy

Yaqi Li, Xingwen Fan, Qi Yu et al. · International Journal of Radiation Oncology*Biology*Physics · 2022 · 26 citations

The prognostic value of tumor depth for cervical lymph node metastasis in hypopharyngeal and supraglottic carcinomas

Lu‐Lu Ye, Jia Rao, Xingwen Fan et al. · Head & Neck · 2019 · 21 citations · Full text